Abstract
Early work on viral hepatitis relied on biochemical methods and microscopy, but the field greatly benefited from the use of primates and other animal models of both acute and chronic infection Use of tumour-derived cells lines has increased our understanding of viral hepatitis; small molecule screens were performed in cell lines expressing viral genomes to identify agents that could suppress viral replication Primary human hepatocytes are considered the most biologically relevant in vitro model for viral hepatitis infections; advances in propagation of stem cells in culture have led to exciting new stem-cell-derived hepatocyte models Hepatocytes and other epithelial cells exist and function in a highly structured system and in vitro models are moving to those that incorporate multiple nonparenchymal cells and 3D lattices to preserve full hepatocyte function Mouse models were initially limited by species-specific barriers, but transgenic animals can used to study immune responses and species-specific barriers can be overcome through the generation of humanized mice Further progress in recapitulating human immune responses in mouse models might facilitate the development of an HCV vaccine, with in vitro models of HBV cccDNA persistence aiding discovery of anti-HBV small molecules

This publication has 170 references indexed in Scilit: